IMATINIB MAINTENANCE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) FOR PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE (PH plus ) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)

被引：0
|
作者：
Kebriaei, P. [1 ]
Chiattone, A. [1 ]
Saliba, R. [1 ]
Jones, D. [1 ]
Anderlini, P. [1 ]
Andersson, B. [1 ]
Khouri, I [1 ]
Worth, L. [1 ]
Ravandi, F. [1 ]
Thomas, D. [1 ]
Kantarjian, H. [1 ]
Hamerschlak, N. [2 ]
Rodrigues, M. [2 ]
de Lima, M. [1 ]
Giralt, S. [1 ]
Champlin, R. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Albert Einstein Israeli Hosp HIAE, Sao Paulo, Brazil
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.232
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
195
引用
收藏
页码：S230 / S230
页数：1
相关论文
共 50 条
  • [31] The Use of Imatinib with Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation Improves Survival of Philadelphia Positive Acute Lymphoblastic Leukemia in Adults
    Perez-Nunez, Josefina
    Jimenez-Velasco, Antonio
    Hurst, Katy
    Barrios-Garcia, Manuel
    Moreno, M. J.
    Heiniger Mazo, Ana Isabel
    BLOOD, 2014, 124 (21)
  • [32] A Chemotherapy-Free Induction Followed by Allogeneic HSCT for Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph plus ALL)
    Leonard, Jessica T.
    Allen, Bryon
    Slater, Susan
    Maziarz, Richard T.
    Hayes-Lattin, Brandon
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S287 - S288
  • [33] The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Zhang, Fu-Hua
    Ling, Yi-Wen
    Zhai, Xiao
    Zhang, Yu
    Huang, Fen
    Fan, Zhi-Ping
    Zhou, Hong-Sheng
    Jiang, Qian-Li
    Sun, Jing
    Liu, Qi-Fa
    HEMATOLOGY, 2013, 18 (03) : 151 - 157
  • [34] Treatment outcome with imatinib-based maintenance therapy in elderly patients with Philadelphia-positive acute lymphoblastic leukaemia (Ph plus ALL) ineligible for allogeneic stem cell transplantation (SCT)
    Pfeifer, Heike
    Wassmann, Barbara
    Wystub, Sylvia
    Wunderle, Lydia
    Chromik, Joerg
    Brueck, Patrick
    Hochhaus, Andreas
    Binckebanck, Anja
    Hoelzer, Dieter
    Ottmann, Oliver
    BLOOD, 2007, 110 (11) : 829A - 829A
  • [35] Outcome of relapsed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) after allogeneic hematopoietic cell transplantation (HCT)
    Heyn, Sinione
    Krahl, Rainer
    Lange, Thoralf
    Eisfeld, Ann-Kathrin
    Niederwieser, Dietger
    Al-Ali, Haifa K.
    BLOOD, 2007, 110 (11) : 948A - 948A
  • [36] Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib
    Tiribelli, Mario
    Sperotto, Alessandra
    Candoni, Anna
    Simeone, Erica
    Buttignol, Silvia
    Fanin, Renato
    LEUKEMIA RESEARCH, 2009, 33 (01) : 174 - 177
  • [37] Comparison of autologous and allogeneic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia
    Lyu, Mengnan
    Jiang, Erlie
    He, Yi
    Yang, Donglin
    Ma, Qiaoling
    Pang, Aiming
    Zhai, Weihua
    Wei, Jialin
    Huang, Yong
    Zhang, Guixin
    Zhang, Rongli
    Feng, Sizhou
    Han, Mingzhe
    HEMATOLOGY, 2021, 26 (01) : 65 - 74
  • [38] Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
    Ottmann, Oliver G.
    Wassmann, Barbara
    Pfeifer, Heike
    Giagounidis, Aristoteles
    Stelljes, Matthias
    Duehrsen, Ulrich
    Schmalzing, Marc
    Wunderle, Lydia
    Binckebanck, Anja
    Hoelzer, Dieter
    CANCER, 2007, 109 (10) : 2068 - 2076
  • [39] Nilotinib in patients (pts) with relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL) who are resistant or intolerant to imatinib
    Ottmann, Oliver G.
    Larson, Richard A.
    Kantarjian, Hagop M.
    le Coutre, Philipp
    Baccarani, Michele
    Haque, Ariful
    Gallagher, Neil
    Giles, Francis
    BLOOD, 2007, 110 (11) : 828A - 828A
  • [40] Maxizyme, a novel ribozyme, induces cell death of Philadelphia chromosome positive acute lymphoblastic leukemia (Ph plus ALL).
    Soda, Y
    Tani, K
    Bai, YS
    Chen, MH
    Izawa, K
    Saiki, M
    Kuwabara, T
    Warashina, M
    Tanabe, T
    Miyoshi, H
    Sugita, K
    Nakazawa, S
    Tojo, A
    Taira, K
    Asano, S
    BLOOD, 2002, 100 (11) : 656A - 656A
12345